Correlation Between Prime Medicine, and Barclays ETN
Can any of the company-specific risk be diversified away by investing in both Prime Medicine, and Barclays ETN at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prime Medicine, and Barclays ETN into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Prime Medicine, Common and Barclays ETN Select, you can compare the effects of market volatilities on Prime Medicine, and Barclays ETN and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prime Medicine, with a short position of Barclays ETN. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prime Medicine, and Barclays ETN.
Diversification Opportunities for Prime Medicine, and Barclays ETN
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Prime and Barclays is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Prime Medicine, Common and Barclays ETN Select in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Barclays ETN Select and Prime Medicine, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prime Medicine, Common are associated (or correlated) with Barclays ETN. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Barclays ETN Select has no effect on the direction of Prime Medicine, i.e., Prime Medicine, and Barclays ETN go up and down completely randomly.
Pair Corralation between Prime Medicine, and Barclays ETN
Given the investment horizon of 90 days Prime Medicine, Common is expected to under-perform the Barclays ETN. In addition to that, Prime Medicine, is 6.35 times more volatile than Barclays ETN Select. It trades about -0.04 of its total potential returns per unit of risk. Barclays ETN Select is currently generating about 0.19 per unit of volatility. If you would invest 2,004 in Barclays ETN Select on September 4, 2024 and sell it today you would earn a total of 974.00 from holding Barclays ETN Select or generate 48.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Prime Medicine, Common vs. Barclays ETN Select
Performance |
| Timeline |
| Prime Medicine, Common |
| Barclays ETN Select |
Prime Medicine, and Barclays ETN Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Prime Medicine, and Barclays ETN
The main advantage of trading using opposite Prime Medicine, and Barclays ETN positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prime Medicine, position performs unexpectedly, Barclays ETN can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Barclays ETN will offset losses from the drop in Barclays ETN's long position.| Prime Medicine, vs. Agilent Technologies | Prime Medicine, vs. Equillium | Prime Medicine, vs. 23Andme Holding Co | Prime Medicine, vs. DiaMedica Therapeutics |
| Barclays ETN vs. Alerian Energy Infrastructure | Barclays ETN vs. UBS AG London | Barclays ETN vs. First Trust North | Barclays ETN vs. Tortoise North American |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |